197 related articles for article (PubMed ID: 30822238)
1. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
Suissa S; Ernst P
COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
[TBL] [Abstract][Full Text] [Related]
2. Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned.
Suissa S; Ernst P
Chest; 2018 Aug; 154(2):257-265. PubMed ID: 29679596
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker use and COPD mortality: a systematic review and meta-analysis.
Etminan M; Jafari S; Carleton B; FitzGerald JM
BMC Pulm Med; 2012 Sep; 12():48. PubMed ID: 22947076
[TBL] [Abstract][Full Text] [Related]
4. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Aspirin in COPD: Biases in the Observational Studies.
Bakshi A; Suissa S
COPD; 2021 Aug; 18(4):449-455. PubMed ID: 34396883
[TBL] [Abstract][Full Text] [Related]
6. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
7. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
8. Statins and Mortality in COPD: A Methodological Review of Observational Studies.
Sule NO; Suissa S
COPD; 2023 Dec; 20(1):284-291. PubMed ID: 37555454
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) - Study protocol from a randomized controlled trial.
Sundh J; Magnuson A; Montgomery S; Andell P; Rindler G; Fröbert O;
Trials; 2020 Jan; 21(1):123. PubMed ID: 32000825
[TBL] [Abstract][Full Text] [Related]
10. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
[TBL] [Abstract][Full Text] [Related]
11. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
12. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers in COPD: A systematic review based on recent research.
Li XF; Mao YM
Life Sci; 2020 Jul; 252():117649. PubMed ID: 32275936
[TBL] [Abstract][Full Text] [Related]
14. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
Leitao Filho FS; Choi L; Sin DD
Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
Gulea C; Zakeri R; Alderman V; Morgan A; Ross J; Quint JK
Respir Res; 2021 Feb; 22(1):64. PubMed ID: 33622362
[TBL] [Abstract][Full Text] [Related]
17. β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study.
Andell P; Erlinge D; Smith JG; Sundström J; Lindahl B; James S; Koul S
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25854796
[TBL] [Abstract][Full Text] [Related]
18. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD?
Baselli LM; Oswald MA; Nashelsky JM
J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911
[No Abstract] [Full Text] [Related]
19. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
Du Q; Sun Y; Ding N; Lu L; Chen Y
PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
[TBL] [Abstract][Full Text] [Related]
20. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
